mRNA-1215

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1215, covering 2025-10-23 to 2025-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults [Phase 1]

See pricing